
Overview
Canada pharmacy service provider's Q4 revenue slightly beat analyst expectations
Adjusted EBITDA for Q4 also beat expectations
Company commenced paying dividends and repurchased shares in 2025
Outlook
CareRx declares Q1 2026 dividend of C$0.02 per share payable April 9, 2026
Company aims to capture growth through home operator expansion plans
CareRx focuses on efficient scaling to drive future growth
Result Drivers
BED GROWTH - Increase in average beds serviced to 92,250 in Q4 2025 from 87,658 in Q4 2024 contributed to revenue growth
COST SAVINGS - Adjusted EBITDA margin improved due to cost savings initiatives
PLATFORM EXPANSION - Expanded platform with over 4,500 additional beds supports growth potential
Company press release: ID:nNFCD05mb
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue | Slight Beat* | C$96.08 mln | C$95.27 mln (3 Analysts) |
Q4 Net Income |
| C$23.79 mln |
|
Q4 Adjusted EBITDA | Beat | C$8.81 mln | C$8.47 mln (3 Analysts) |
Q4 Adjusted EBITDA Margin |
| 9.20% |
|
Q4 EBITDA |
| C$7.10 mln |
|
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.